Tag: corbus
March 12, 2018
Corbus Pharmaceuticals Reports 2017 Financial Results and Provides Clinical Update
Corbus Pharmaceuticals (NASDAQ: CRBP) a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat... January 31, 2018
Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design
Corbus Pharmaceuticals (NASDAQ: CRBP) a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced that... December 22, 2017
Corbus Pharmaceuticals Kicks Off Phase 2 Study
Corbus Pharmaceuticals Holdings announced the start of their phase 2 clinical study of anabasum, treating systemic lupus erythematosus. December 14, 2017
Corbus Kicks Off Phase 3 Study RESOLVE-1
Corbus Pharmaceuticals Holdings announced it started their Phase 3 study for the efficacy and safety of anabasum in the treatment... November 27, 2017
Corbus Gets Patent Covering Use of Anabasum for the Treatment of Rare Fibrotic Diseases
Corbus Pharmaceuticals announced it received a patent from the US Patent and Trademark Office covering the use of pharmaceutical compositions... November 8, 2017
Corbus Reports 2017 Third Quarter Financial Results
Corbus Pharmaceuticals Holdings released their financial report for the third quarter of 2017. October 31, 2017